Evidence map›Paper›PMID 39400083›Full record

Trial reportOral health & preventive dentistry2024

Daily Probiotic Ayran Intake Reduces Gingival Inflammation: An Experimental Gingivitis Study.

Bahar Alkaya, Mehmet Cenk Haytac, Mustafa Özcan, Onur Uçak Türer, Hamza Gökhan Kayhan, Furkan Demirbilek, Wim Teughels

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Oral health & preventive dentistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bahar Alkaya
Mehmet Cenk Haytac
Mustafa Özcan
Onur Uçak Türer
Hamza Gökhan Kayhan
Furkan Demirbilek
Wim Teughels

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study investigates the effects of daily consumption of a probiotic ayran drink on gingival inflammation and the development of experimental gingivitis. MATERIALS AND

methodsThis randomised, double-blind, placebo-controlled trial involved 54 volunteer students. The participants were randomly assigned to two groups: the control group received regular ayran for 42 days, while the test group received probiotic enriched ayran (including Lactobacillus acidophilus and Bifidobacterium bifidum) for 42 days twice a day. After 42 days, mechanical plaque control was stopped for 5 days. The plaque index (PI), gingival index (GI), probing bleeding (BOP), and probing depth (PPD) were measured at baseline, day 42, and day 47. At the same time, gingival crevicular fluid was taken for matrix metalloproteinase-8 examination.

resultsThe mean scores of BOP, GI, PI, and MMP-8 levels increases in both groups following the 5-day experimental gingivitis period compared to baseline and day 42. Patients using probiotic ayran had significantly less PI, GI, BOP scores and MPP-8 values (p = 0.002; p 0.001; p 0.001; p = 0.001; p = 0.001, respectively) at day 47 compared to the control group. No statistically significant differences in probing pocket depth (PPD) were observed at any time point.

conclusionThe present study suggests that daily consumption of a probiotic ayran drink containing Lactobacillus acidophilus and Bifidobacterium bifidum statistically significantly lowers clinical and immunological markers of gingival inflammation.

Indexed as

Dental Plaque IndexGingival Crevicular FluidGingivitisLactobacillus acidophilusMatrix Metalloproteinase 8Periodontal IndexProbioticsAdultBifidobacterium bifidumDouble-Blind MethodFemaleFollow-Up StudiesGingival HemorrhageHumansMalePeriodontal PocketMatrix Metalloproteinase 8MMP8 protein, humanPlacebosayranBifidobacterium bifidumdairy productsdental plaqueexperimental gingivitisLactobacillus acidophilusoral healthprobiotics

Identifiers

PMID39400083
PMCPMC11619859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.